Quanterix commits to workforce reduction targeting $18M annual savings post-Akoya integration

Quanterix Corp

Termination plan committed July 18, 2025, to reduce operating costs and preserve cash.
Annualized cash savings expected ~$18.0 million from headcount reductions, substantially completed in Q3 2025.
Severance expenses of ~$2.5 million, all cash expenditures in 2025.
Integration plan to realize synergies from acquisition of Akoya Biosciences, Inc.

item 2.05item 9.01

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.